Targeting bladder outlet obstruction from benign prostatic enlargement via the nitric oxide/cGMP pathway?

BJU Int. 2005 Aug;96(3):250-3. doi: 10.1111/j.1464-410X.2005.05612.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Cyclic GMP / metabolism*
  • Humans
  • Male
  • Muscle Relaxation / physiology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / therapeutic use
  • Phosphodiesterase Inhibitors / therapeutic use
  • Prostatic Hyperplasia / drug therapy*
  • Prostatic Hyperplasia / metabolism
  • Urinary Bladder Neck Obstruction / metabolism
  • Urinary Bladder Neck Obstruction / prevention & control*

Substances

  • Nitric Oxide Donors
  • Phosphodiesterase Inhibitors
  • Nitric Oxide
  • Cyclic GMP